K2 Principal Fund, L.P. Teva Pharmaceutical Industries LTD Call Options Transaction History

K2 Principal Fund, L.P.

  • $210 Million
  • Q3 2024

Call Options

2 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2018

Feb 13, 2019
SELL
$14.59 - $23.84 $729,500 - $1.19 Million
-50,000 Closed
0 $0
Q3 2018

Nov 13, 2018
BUY
$21.06 - $25.65 $1.05 Million - $1.28 Million
50,000 New
50,000 $1.08 Million

Others Institutions Holding TEVA

# of Institutions
640
Shares Held
580M
Call Options Held
19.6M
Put Options Held
6.77M
View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

TEVA Quotes by TradingView
  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19.1B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track K2 Principal Fund, L.P. Portfolio

Follow K2 Principal Fund, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of K2 Principal Fund, L.P., based on Form 13F filings with the SEC.

News

Stay updated on K2 Principal Fund, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email